跳至主要内容
临床试验/NCT00955617
NCT00955617已完成4 期

Intra-individual Efficacy Evaluation of DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in the Diagnosis of Clinically Significant Abdominal or Lower Limb Arterial Diseases

Guerbet1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2009年7月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Guerbet
入组人数
20
试验地点
1
主要终点
Overall Image Quality of MRA Images

研究概览

简要总结

This study is an intra-individual comparison of DOTAREM®-enhanced MRA and GADOVIST®-enhanced MRA in the diagnosis of clinically significant abdominal or lower limb arterial diseases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Female or male, aged ≥ 18 years
  • Patient suffering from Peripheral Arterial Occlusive Disease (PAOD) stage II or III.

排除标准

  • Patients with severely impaired renal function with an eGFR (MDRD) < 50ml/min (eGFR based on recent serum creatinine and MDRD formula - younger than 21 days).
  • Patient planned to undergo therapeutic intervention in the vessels of interest between the two MRA procedures.
  • Patient who had a major cardiovascular event within 30 days prior to the inclusion.

结局指标

主要结局

Overall Image Quality of MRA Images

时间窗: MRA examination

Number of images quoted with excellent and more than adequate quality in each group. Image quality will be assessed on a 5-point scale: 1. Excellent 2. More than adequate 3. Adequate 4. Less than adequate 5. Non-diagnostic Each image is analysed by 4 readers.

次要结局

  • Diagnostic Confidence(MRA examination)
  • Signal Intensity(MRA examination)

研究者

发起方
Guerbet
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验